General Bacteriology Summary Flashcards

1
Q

What bacteria does not have Peptidoglycan?

A

Chlamydia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which test detects endotoxin/Lipid A?

A

Limulus amebocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bacteria structure summary

A

Prokaryotes (no nucleus), complex cell wall, no sterol, no membrane bound organelles, singular circular chromosome, no histones, ribosomes, no cytoskeleton, asexual reproduction (binary fission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Flagella purpose

A

locomotion or motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fimbriae or pili purpose

A

adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Endoflagella/axial filaments present in…?

A

Spirochetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Capsule purpose

A

Evade phagocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Spore purpose

A

bacterial survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F Size of bacteria is not critical to virulence of the species

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define: Pathogenicity

A

ability of a pathogen to produce a disease by overcoming the defense mechanisms of the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define: Virulence

A

degree of pathogenicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Factors contributing to virulence

A
  1. Number of organisms
  2. Virulence factors
  3. Status of host immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Damage caused by bacteria

A

Using hosts nutrients,
direct damage to host cell (toxins),
hypersensitivity reactions,
type 4 hypersensitivity-Tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of bacterial morphology is not common in clinical isolates

A

Gram Negative Cocci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fungus Summary

A
Eukaryotes, 
sterols (ergosterol) in cell membrane, 
no peptidoglycan (contains glucans, mannans, chitin)
yeast-unicellular, 
mold-multicellular (hyphae)
dimorphic fungus, 
sexual and asexual reproduction
polyphasic approach needed (morphology and DNA sequencing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Detection of the infectious agent

A

Direct staining
Culture
ELISA (Ag detection)
PCR (Molecular detection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Detection of the host immune response

A

Antibody detection (ELISA, Agglutination, precipitation, immunochromatography) and detection of cell mediated immune response (intradermal tests (tuberculin test), lymphocyte proliferation test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antibody Titer

A

It is the highest dilution of the serum sample which give a positive result in a particular test

remember: positive titer is not always diagnostic!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Does 1:256 or 1:16 Antibody titer have more antibodies?

A

1:256

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Paired serology titers

A

compare acute and convalescent phase samples

Four fold increase in serum titers are indicative of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

T/F Any bacteria can opportunistically infect any of the body systems

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Define: systemic disease

A

Affect multiple systems of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When do you use antimicrobial therapy?

A

When the patient has a treatable microbial infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is MIC?

A

Minimum inhibitory concentration: minimum amount of drug required to inhibit bacterial growth, drugs with lower MIC values are better choices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is a susceptibility break point?

A

a drug concentration above which an organism is considered resistant and at or below this value organism is susceptible to that drug, three values (susceptible, intermediate, resistant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Disk Diffusion “Kirby Bauer”

A

**Must use a bacterial isolate in pure culture,
single concentration antimicrobial disks,
growth inhibition zone diameter measured,
published reference breakpoints to interpret results,
qualitative- will not give you accurate MIC values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which is more commonly seen- Full range or partial range MIC?

A

Partial range (breakpoint) MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Gradient diffusion test- E-test

A

***(diffusion and dilution)

can give you MIC values, but strips are very expensive

29
Q

Time dependent killing

A

length of time bacteria are exposed to these antibiotics at a concentration above MIC,
frequent dosing or constant infusions

30
Q

Concentration dependent killing

A

rate of killing increases as the drug concentration in plasma increases above MIC,
high dosing at long intervals (once daily)
prolonged post antibiotic effect

31
Q

concentration dependent killing antimicrobial drugs

A

fluoroquinolones, aminoglycosides, metronidazole

32
Q

time dependent killing antimicrobial drugs

A

beta-lactams, macrolides, tetracyclines, lincosamides, chloriamphenicol potentiated sulfonmides
cefovecin exception-binds above MIC for 7 days

33
Q

Antimicrobials involved with cell wall/cell membrane

A

beta-lactams (penicillin, ampicillin, cephalosporins, imipenem), glycopeptides (vancomycin), bacitracin, polymyxin

34
Q

Antimicrobials involved with protein synthesis

A

tetracyclines, macrolides, aminoglycosides, chloramphenicol, lincosamides, streptogramins

35
Q

Antimicrobials involved with nucleic acid synthesis inhibition

A

sulfonamides/trimethoprim- folic acid synthesis (purine metabolism)
nitroimidazoles/nitrofurans
fluoroquinolons (enrofloxacin, ciprofloxacin)
novobiocin,
rifampin (RNA)

36
Q

Antifungal drugs

A

polyens, azoles, bind to ergosterols

37
Q

types of resistence

A

Innate resistance- preexisting genomic property

Acquired resistance- by mutation or horizontal gene transfer

38
Q

which bacteria does not have a single circular chromosome?

A

Borrelia- linear chromosome

upregulation of OSP-variation, evades the immune system

39
Q

Gram negative summary

A

only cell type that has outer membrane
lipopolysaccharide (LPS)- lipid A/endotoxin is harmful
Limulus amebocyte test to see lipid A

40
Q

Gram positive summary

A

contain teichoic acid on cell walls

thick peptidoglycan layer

41
Q

mycobacteria morphology summary

A

mycolic acid
contribute to acid fast positive staining
(but not the only acid fast bacteria!!!!)

42
Q

Bacterial virulence factors

A

fimbriae, flagella, capsule, toxins (exotoxins and endotoxins), superantigens
transfer of these through plasmids and bacteriophages by conjugation, transformation and transduction
quorum sensing
biofilms

43
Q

Why is it important to know what type of pathogenicity a bacteria has? (opportunisitc, obligate nosocomial, obligate vs. facultative intracellular)

A

because you need to know these to be able to treat it

44
Q

Staphylococcus summary

A
Gram + cocci (clusters)
facultative anaerobe
superantigen= enterotoxin
suppurative conditions
catalase positive
45
Q

Streptococcus summary

A
Gram + cocci (pairs or chains)
has M protein and teichoic acid
superantigen
catalase negative
beta hemolytic (pyogenic)
46
Q

What is the morphology of Rhodococcus

A

Gram + rod
aerobe
zoonotic
mycolic acid/acid fast +

47
Q

Bacillus anthracis summary

A
polymers of D glutamic acid
spore forming (large spores)
\+ mcfadyean reaction- pink capsule
infectious, not contagious
aerobe (bacillus sp is facultative anaerobe)
48
Q

what bacteria are acid fast +

A

corynebacterium (partial)
rhodococcus (partial)
nocardia (partial)
mycobacterium

all are facultative intracellular

49
Q

which bacteria are gram - anaerobes

A

fusobacterium
bacteriodes
dichelobacter

50
Q

which bacteria are gram - spirochetes

A

brachyspira
borrelia
leptospira
treponema

51
Q

Cell wall deficient bacteria

A

mycoplasma

ureaplasma

52
Q

gram - spiral bacteria

A

campylobacter
helicobacter
lawsonia

53
Q

What bacteria has sterols in its cell membrane?

A

mycoplasma

54
Q

what is seroconversion

A

antibody development after exposure to a pathogen or an antigen

55
Q

things to remember about test results

A
  1. generation or an immune repsonse requires time

2. immune response may persist

56
Q

what causes false positive

A

prior antigen exposure
vaccination
cross-reactions

(sampling, transport, storage issues, antimicrobial therapy, presence of fastidious organisms, or when specific procedures are needed)

57
Q

what causes false negative

A

early stages of infection
late in infection due to anergy
immunosuppression

(sampling, transport, storage issues, antimicrobial therapy, presence of fastidious organisms, or when specific procedures are needed)

58
Q

Antibacterial susceptibility testing

A
  1. dilution (broth/agar)

2. diffusion (disk)

59
Q

Susceptibility results interpretation

A

S(susceptible)- high likelihood of therapeutic success
I (intermediate)- uncertain therapeutic outcome
R(resistent)- high likelihood of therapeutic failure

60
Q

Broth diluartion

A

multiple dilutions of antimicrobial agents (usually 2 fold serial diluations)
use published reference breakpoints to interpret
measure and report growth inhibition endpoint (MIC- micrograms/mL)

61
Q

bactericidal drugs

A

beta lactams, aminoglycosides

62
Q

bacteriostatic drugs

A

chloramphenicol, tetracyclines

63
Q

broad spectrum anitbiotic

A

tetracycline

64
Q

narrow spectrum antibiotic

A

penicillin

65
Q

antimicrobial combinations

A
  1. to obtain antimicrobial synergism (ex. beta lactam aminoglycoside, sulfonamides/trimethoprim)
  2. to treating polymicrobial infections (peritonitis/aspiration pneumonia)
  3. to decrease the emergence of antimicrobial resistance (mycobacterial inf)
  4. to reduce drug toxicity (flucytosine and amphorecin B in cryptococcal meningitis)
66
Q

emergence of antimicrobial resistance

A
widespread antimicrobial use
microbial adaptation and change
changes in demopgraphics
medical advances
changes in ecosystems
cutbacks in public health systems
67
Q

mechanisms of resistance

A

enzymatic destruction of inactivation of drug
prevention of penetration to target site within microbe
alteration of drugs target site
rapid efflux of antibiotics

68
Q

potential impact of antimicrobial resistence

A
increased mortality due to infectious diseases
vet revisits
high treatment costs
productivity loss and economic impact
zoonotic spread of resistant microbes
increased nosocomial infections
69
Q

antibiotic misuse

A

providers- over prescription, over selection of broad spectrum, costly, last resort durgs
clients/patients- noncompliance, stockpiling, self medication/OTC
use in livestock rations for growth promotion and prophylaxis (80-90% of use in agriculture)